Status:
COMPLETED
Prevalence of Delayed Chemotherapy Associated Nausea
Lead Sponsor:
Antje Koller
Collaborating Sponsors:
ZETUP St. Gallen
Dr.-Hans-Altschüler-Stiftung
Conditions:
Chemotherapy-induced Nausea and Vomiting
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates the prevalence of delayed chemotherapy induced nausea in adult oncology patients in real clinical practice of day clinics.
Detailed Description
Chemotherapies are rated to have a high to minimal emetogenic potential in oncology patients. Their potential to induce delayed nausea is supposed to often be higher than their emetogenic potential. H...
Eligibility Criteria
Inclusion
- first day of chemotherapy of a new cycle (any cycle)
- speak and write German
- sign the consent forms
Exclusion
- cognitive or linguistic impairments that would significantly impede consent or participation (as assessed by the nurses in charge)
- accompanying radiotherapy;
- pre-existing nausea within three days before the start of the first chemotherapy in this cycle; and
- prior participation in CINrate (each person participates only once)
Key Trial Info
Start Date :
June 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT04342780
Start Date
June 29 2020
End Date
May 31 2022
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ZeTuP
Sankt Gallen, Switzerland, 9000